Press Releases
Catalent Adds New High-Throughput Encapsulation Manufacturing Suites at Kansas City, Missouri, Facility
Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across...
Press Releases
AmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and Japan
Amoy Diagnostics Co., Ltd (AmoyDx), a China based innovative molecular diagnostics company (SZSE: 300685), today announces that it has entered into a Master Collaboration...
Press Releases
Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan
Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovidยฎ Intramuscular Injection...
Press Releases
Thermo Fisher Scientific Launches New GMP-manufactured Cas9 Protein
As researchers using genome editing tools move from basic research to clinical settings, high-quality ancillary materials and documentation are critical. To help researchers meet...
News
More COVID Cases In Shanghai Lead To Stiffer City-Wide Bans
On April 16th, Shanghai reported a new high for symptomatic COVID-19 cases, while other cities throughout China tightened controls as the country continued its...
News
Is It Really Possible To Attain COVID-19 Herd Immunity?
The fresh, new, astonishingly efficient COVID-19 vaccines were rolling out across the USย this time last year, injecting a strong note of confidence into the...
Press Releases
Takeda partners with Engitix to to develop new anti-fibrotic therapies
Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, entered...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















